Impact of drug resistance mutations on virologic response to salvage therapy

1999206 citationsJournal Article

Authors

Patrizio Lorenzi · Novem (Netherlands)

Milos Opravil · Novem (Netherlands)

Bernard Hirschel · Novem (Netherlands)

Jean-Philippe Chave · Novem (Netherlands)

H Furrer · Novem (Netherlands)

Hugo Sax · Novem (Netherlands)

Thomas Perneger ·

Abstract

In patients with advanced HIV infection, the virological response to salvage therapy containing nelfinavir is best predicted by the number of baseline RT inhibitor plus protease inhibitor-resistance mutations.

Topics & Keywords

HIV/AIDS drug development and treatment HIV Research and Treatment Hepatitis C virus research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: AIDS

Volume 13, Issue 2, pp. F17-F21

DOI: 10.1097/00002030-199902040-00001

Field-Weighted Citation Impact: 19.14